glp-1 news today september 29 2025 Medscape | Semaglutide, a second-generation receptor agonist, was associated with significantly reduced body weight and other metabolic factors Ozempic GLP-1 Pitfalls and Natural

vehicle within genotype or comparison indicated by bracket

Obesity is considered a chronic medical condition

5 Discussion GLP-1RAs have emerged as a paradigm-shifting class of agents, with therapeutic benefits that extend well beyond glycemic control in type 2 diabetes

Now that the FDA has determined the drug shortage for semaglutide has been resolved, we will continue to offer access to personalized treatments as allowed by law to meet patient needs, Hims CEO Andrew Dudum wrote in a post on X $TWTR in February

Why This Matters for Men Already on Testosterone Therapy About 15% of couples in the United States have trouble conceiving, and more than half of those cases involve a male infertility problem, according to Yale Medicine